Several possible studies
Story checked
Atlas Antibodies marks 20 years of Human Protein Atlas–validated antibodies (opens in a new tab)
news-medical.net · 2026-09-30
Short answer
Several possible studiesNo clear answer.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Checked against the study summary. The full text wasn't available, so some details couldn't be settled either way.
Share this check
The story
Atlas Antibodies marks 20 years of Human Protein Atlas–validated antibodies
news-medical.net · 2026-09-30
The story’s checkable claims.
Read the original story (opens in a new tab)NewsLink checks it
Several studies could be the source of this story.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Open claim evidenceSearch result
Several studies could fit.
More than one paper fits the article's details, and none fits well enough to single out. Checking claims against the wrong study would be worse than not checking them at all.
Evidence layer
Claim by claim
What the story asserts. With no source study, there is nothing to check these against.
Reading mode
Scan verdicts. Open evidence only when needed.
Claim 1 of 7Not checkedAtlas Antibodies is 20 years old.View evidenceHide evidence
As stated20 years
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 2 of 7Not checkedThe company is the original manufacturer of the antibodies used to map the human proteome in the Human Protein Atlas.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 3 of 7Not checkedSince 2006, Atlas Antibodies has made these antibodies available to researchers worldwide, and they have been used in thousands of publications.View evidenceHide evidence
As statedthousands of publications
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 4 of 7Not checkedAtlas Antibodies was founded in 2006 by researchers from the Human Protein Atlas project to give the wider research community access to the same antibodies used to map protein expression across human tissues and cells.View evidenceHide evidence
As stated2006
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 5 of 7Not checkedEach antibody starts with a PrEST antigen and is screened on a protein array of 364 human recombinant fragments, then validated in immunohistochemistry on more than 40 normal and cancer tissues; where approved, it is also tested in western blot and ICC-IF.View evidenceHide evidence
As stated364 human recombinant fragments; more than 40 normal and cancer tissues
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 6 of 7Not checkedMany antibodies also pass enhanced validation using orthogonal, genetic, independent antibody, or recombinant expression methods.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Claim 7 of 7Not checkedEach product carries an HPA identifier that can be entered at proteinatlas.org to view the tissue, cell, and blot data behind the product before buying.View evidenceHide evidence
Not checked
NewsLink could not identify one source study, so this claim was not compared against a paper.
Method layer
No single source study was found.
NewsLink still surfaces nearby research so you can inspect the field instead of a single paper.
Nearby research
No exact source, but these papers are close.
PubMed, Europe PMC, Crossref · 15 candidate papers
Integrated Immunotherapy Target Atlas for Ewing Sarcoma.
Cancer Genomics & Proteomics · 2026 · PubMed, Europe PMC
Antibody Pair for Protein Protein Interaction
SciVee · 2010 · Crossref
Multi-Omics Integration and Proteomic Annotation Prioritize FAM174BAssociated Monocyte Remodeling in COPD and Lung Adenocarcinoma.
Current Cancer Drug Targets · 2026 · PubMed, Europe PMC
Figure 2—figure supplement 3. Western blot analysis of tagged proteins observed in S2R+ cells.
Crossref
A multiplex tissue resource for high-resolution spatial protein profiling in the Human Protein Atlas.
2026 · Europe PMC
And 10 more candidates considered.